Immediate Impact
1 from Science/Nature 55 standout
Citing Papers
Targeting and engineering long non-coding RNAs for cancer therapy
2024 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Works of Lichun Deng being referenced
Gunagratinib, a highly selective irreversible FGFR inhibitor, in patients with previously treated locally advanced or metastatic cholangiocarcinoma harboring FGFR pathway alterations: A phase IIa dose-expansion study.
2023
Associations between polymorphisms of long non-coding RNA MEG3 and risk of colorectal cancer in Chinese
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Lichun Deng | 142 | 39 | 45 | 79 | 56 | 16 | 269 | |
| Jinyu Su | 167 | 24 | 46 | 44 | 32 | 20 | 314 | |
| Wenting Ni | 136 | 28 | 41 | 67 | 40 | 14 | 275 | |
| Ling Ning | 129 | 31 | 24 | 39 | 35 | 20 | 320 | |
| Yanan Pi | 167 | 41 | 60 | 83 | 83 | 12 | 321 | |
| Tao Hou | 154 | 49 | 49 | 37 | 27 | 23 | 279 | |
| Shane R. Solst | 144 | 46 | 47 | 67 | 72 | 11 | 314 | |
| Prabhakar Pitta Venkata | 125 | 20 | 33 | 46 | 28 | 15 | 225 | |
| Di Li | 131 | 30 | 46 | 33 | 25 | 22 | 320 | |
| Ramin Khorrami | 180 | 51 | 46 | 75 | 12 | 24 | 298 | |
| Junfeng Yan | 152 | 46 | 37 | 52 | 13 | 27 | 323 |
All Works
Login with ORCID to disown or claim papers
Loading papers...